Fund
Bessemer Venture Partners
Bessemer Venture Partners followed on in the round of Soufflé Therapeutics (135 M$, Series B) on 13 October 2026. It is the only health round Bolus has logged for it so far.
Page built from the operations logged, not from a written profile. It says nothing about the fund's activity outside the scope of Bolus, which is health venture capital in Europe and the United States.
- Operations logged
- 1
- Lead
- 0
- New entries
- 0
- Follow ons
- 1
- Latest operation
- 13 October 2026
- Sectors
- Biotech
Operations
| Date | Company | Stage | Amount | Role |
|---|---|---|---|---|
| 13 Oct | United States, Biotech | Series B | 135 M$ | Existing investor |
Co investors 16 funds crossed
- Amgen Ventures 1 operation
- ARCH Venture Partners 1 operation
- Balyasny Asset Management 1 operation
- BB Biotech 1 operation
- Breyer Capital 1 operation
- Fidelity Management & Research Company 1 operation
- Janus Henderson 1 operation
- Juvia Group 1 operation
- Leaps by Bayer 1 operation
- Polaris Partners 1 operation
- Safar Partners 1 operation
- TAS Partners 1 operation
- TCG Crossover Management 1 operation
- Temasek 1 operation
- The Invus Group 1 operation
- Vida Ventures 1 operation
Funds that appeared in the same rounds, in any capacity. Geographies logged: United States.